Debt restructuring to reduce interest costs by ₹300 cr by FY27: Biocon CEO(Soban News)

CEO Shreehas Tambe says debt reduction, US state tie-ups, and five fresh product launches will strengthen Biocon Biologics’ global biosimilar play

​CEO Shreehas Tambe says debt reduction, US state tie-ups, and five fresh product launches will strengthen Biocon Biologics’ global biosimilar play by Soban News (international And National News)